Excretion of Rivaroxaban in Human Breast Milk

Clinical trial NCT06831474 · RECRUITING

Trial details

NCT number: NCT06831474
Sponsor: Thomas Jefferson University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Postpartum VTE Prophylaxis VTE (Venous Thromboembolism)Rivaroxaban Breastfeeding Breast Milk Collection

Start date: 2025-07-01
Primary completion: 2026-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.